Glial cells potentiate kainate-induced neuronal death in a motoneuron- enriched spinal coculture system

Brain Research

Volumn 807, Issue 1-2, 1998, Pages 1-10

  Vandenberghe, Wim ^a   Van Den Bosch, Ludo ^a   Robberecht, Wim ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Astrocyte; Culture; Differentiation; Excitotoxicity; Kainate; Motoneuron; Mouse

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; KAINIC ACID; METRIZAMIDE; PERIPHERIN;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL SURVIVAL; DRUG RECEPTOR BINDING; EXTRACELLULAR SPACE; GLIA CELL; IMMUNOREACTIVITY; MEMBRANE PERMEABILITY; MOUSE; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD MOTONEURON;

ANIMALS; CALCIUM; CELL COUNT; CELL DEATH; CELL DIFFERENTIATION; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; CELLS, CULTURED; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; KAINIC ACID; MICE; MOTOR NEURONS; NEUROGLIA; NEURONS; SPINAL CORD;

EID: 0032487656     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00569-1     Document Type: Article

References (56)

1. 3H )Glutamate by primary astrocyte cultures: II. Differences in cultures prepared from different brain regions Glia. 6:1992;9-18.
2. Ang L.C., Bhaumick B., Munoz D.G., Sass J., Juurlink B.H.J. Effects of astrocytes, insulin and insulin-like growth factor I on the survival of motoneurons in vitro. J. Neurol. Sci. 109:1992;168-172.
3. Barbin G., Katz D.M., Chamak B., Glowinski J., Prochiantz A. Brain astrocytes express region-specific surface glycoproteins in culture. Glia. 1:1988;96-103.
4. 2+ entry via AMPA/KA receptors and excitotoxicity in cultured cerebellar Purkinje cells. J. Neurosci. 14:1994;187-197.
5. 2+ and in vitro kainate damage to cortical and hippocampal SMI-32(+) neurons. NeuroReport. 6:1995;629-632.
6. Burnashev N., Monyer H., Seeburg P.H., Sakmann B. Divalent ion permeability of AMPA receptor channels is dominated by the edited form of a single subunit. Neuron. 8:1992;189-198.
7. Camu W., Henderson C.E. Purification of embryonic rat motoneurons by panning on a monoclonal antibody to the low-affinity NGF receptor. J. Neurosci. Meth. 44:1992;59-70.
8. Carriedo S.G., Yin H.Z., Weiss J.H. Motor neurons are selectively vulnerable to AMPA/kainate receptor-mediated injury in vitro. J. Neurosci. 16:1996;4069-4079.
9. Chamak B., Fellans A., Glowinski J., Prochiantz A. MAP2 expression and neuritic outgrowth and branching are correlated through region-specific neuro-astroglial interactions. J. Neurosci. 7:1987;3163-3170.
10. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1:1988;623-634.
11. Choi D.W., Maulucci-Gedde M., Kriegstein A.R. Glutamate neurotoxicity in cortical cell culture. J. Neurosci. 7:1987;357-368.
12. Denis-Donini S., Glowinski J., Prochiantz A. Glial heterogeneity may define the three-dimensional shape of mouse mesencephalic dopaminergic neurones. Nature. 307:1984;641-643.
13. Dugan L.L., Bruno V.M.G., Amagasu S.M., Giffard R.G. Glia modulate the response of murine cortical neurons to excitotoxicity: glia exacerbate AMPA neurotoxicity. J. Neurosci. 15:1995;4545-4555.
14. Eagleson K.L., Raju T.R., Bennett M.R. Motoneuron survival is induced by immature astrocytes from developing avian spinal cord. Dev. Brain Res. 17:1985;95-104.
15. Escurat M., Djabali K., Gumpel M., Gros F., Portier M. Differential expression of two neuronal intermediate-filament proteins, peripherin and the low-molecular-mass neurofilament (NF-L), during the development of the rat. J. Neurosci. 10:1990;764-784.
16. Estevez A.G., Stutzmann J., Barbeito L. Protective effect of riluzole on excitatory amino acid-mediated neurotoxicity in motoneuron-enriched cultures. Eur. J. Pharmacol. 280:1995;47-53.
17. Fonnum F. A rapid radiochemical method for the determination of choline acetyltransferase. J. Neurochem. 24:1975;407-409.
18. Frandsen A., Schousboe A. Development of excitatory amino acid induced cytotoxicity in cultured neurons. Int. J. Dev. Neurosci. 8:1990;209-216.
19. Furuyama T., Kiyama H., Sato K., Park H.T., Maeno H., Tagaki H., Tohyama M. Region-specific expression of subunits of ionotropic glutamate receptors (AMPA-type, KA-type and NMDA receptors) in the rat spinal cord with special reference to nociception. Mol. Brain Res. 18:1993;141-151.
20. Gottron F., Turetsky D., Choi D.W. SMI-32 antibody against non-phosphorylated neurofilaments identifies a subpopulation of cultured cortical neurons hypersensitive to kainate toxicity. Neurosci. Lett. 194:1995;1-4.
21. Hewett S.J., Csernansky C.A., Choi D.W. Selective potentiation of NMDA-induced neuronal injury following induction of astrocytic iNOS. Neuron. 13:1994;487-494.
22. 2+ permeability of KA-AMPA-gated glutamate receptor channels depends on subunit composition. Science. 252:1991;851-853.
23. Hugon J., Vallat J.M., Spencer P.S., Leboutet M.J., Barthe D. Kainic acid induces early and delayed degenerative neuronal changes in rat spinal cord. Neurosci. Lett. 104:1989;258-262.
24. Jakowec M.W., Yen L., Kalb R.G. In situ hybridization analysis of AMPA receptor gene expression in the developing rat spinal cord. Neuroscience. 67:1995;909-920.
25. Köller H., Siebler M., Schmalenbach C., Muller H. GABA and glutamate receptor development of cultured neurons from rat hippocampus, septal region, and neocortex. Synapse. 5:1990;59-64.
26. Lee S.H., Kim W.T., Cornell-Bell A.H., Sontheimer H. Astrocytes exhibit regional specificity in gap-junction coupling. Glia. 11:1994;315-325.
27. Levi G., Patrizio M. Astrocyte heterogeneity: endogenous amino acid levels and release evoked by non-N-methyl-D-aspartate receptor agonists and by potassium-induced swelling in type-1 and type-2 astrocytes. J. Neurochem. 58:1992;1943-1952.
28. Mattson M.P., Rychlik B. Glia protect hippocampal neurons against excitatory amino acid-induced degeneration: involvement of fibroblast growth factor. Int. J. Dev. Neurosci. 8:1990;399-415.
29. Mattson M.P., Dou P., Kater S.B. Outgrowth-regulating actions of glutamate in isolated hippocampal pyramidal neurons. J. Neurosci. 8:1988;2087-2100.
30. Metzger F., Wiese S., Sendtner M. Effect of glutamate on dendritic growth in embryonic rat motoneurons. J. Neurosci. 18:1998;1735-1742.
31. Parpura V., Basarsky T.A., Liu F., Jeftinija K., Jeftinija S., Haydon P.G. Glutamate-mediated astrocyte-neuron signalling. Nature. 369:1994;744-746.
32. Pellegrini-Giampietro D.E., Fan S., Ault B., Miller B.E., Zukin R.S. Glutamate receptor gene expression in spinal cord of arthritic rats. J. Neurosci. 14:1994;1576-1583.
33. Peterson C., Neal J.H., Cotman C.W. Development of N-methyl-D-aspartate excitotoxicity in cultured hippocampal neurons. Dev. Brain Res. 48:1989;187-195.
34. Petralia R.S., Wang Y.X., Mayat E., Wenthold R.J. Glutamate receptor 2-selective antibody shows a differential distribution of calcium-impermeable AMPA receptors among populations of neurons. J. Comp. Neurol. 385:1997;456-476.
35. Pruss R.M., Akeson R.L., Racke M.M., Wilburn J.L. Agonist-activated cobalt uptake identifies divalent cation-permeable kainate receptors on neurons and glial cells. Neuron. 7:1991;509-518.
36. Ransom B.R., Neale E., Henkart M., Bullock P.N., Nelson P.G. Mouse spinal cord in cell culture: I. Morphology and intrinsic neuronal electrophysiologic properties. J. Neurophysiol. 40:1977;1132-1150.
37. Regan R.F. The vulnerability of spinal cord neurons to excitotoxic injury: comparison with cortical neurons. Neurosci. Lett. 213:1996;9-12.
38. Regan R.F., Choi D.W. Glutamate neurotoxicity in spinal cord cell culture. Neuroscience. 43:1991;585-591.
39. Rosenberg P.A., Amin S., Leitner M. Glutamate uptake disguises neurotoxic potency of glutamate agonists in cerebral cortex in dissociated cell culture. J. Neurosci. 12:1992;56-61.
40. Rothstein J.D., Jin L., Dykes-Hoberg M., Kuncl R.W. Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc. Natl. Acad. Sci. USA. 90:1993;6591-6595.
41. Rothstein J.D., Dykes-Hoberg M., Pardo C.A., Bristol L.A., Jin L., Kuncl R.W., Kanai Y., Hediger M.A., Wang Y., Schielke J.P., Welty D.F. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron. 16:1996;675-686.
42. Schnaar R.L., Schaffner A.E. Separation of cell types from embryonic chicken and rat spinal cord: characterization of motoneuron-enriched fractions. J. Neurosci. 1:1981;204-217.
43. Shaw P.J. Excitotoxicity and motor neurone disease: a review of the evidence. J. Neurol. Sci. 124(Suppl):1994;6-13.
44. Sternberger L.A., Sternberger N.H. Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments in situ. Proc. Natl. Acad. Sci. USA. 80:1983;6126-6130.
45. Sugiyama K., Brunori A., Mayer M.L. Glial uptake of excitatory amino acids influences neuronal survival in cultures of mouse hippocampus. Neuroscience. 32:1989;779-791.
46. Tandan R., Bradley W.G. Amyotrophic lateral sclerosis: Part 1. Clinical features, pathology, and ethical issues in management. Ann. Neurol. 18:1985;271-280.
47. Tölle T.R., Berthele A., Zieglgänsberger W., Seeburg P.H., Wisden W. The differential expression of 16 NMDA and non-NMDA receptor subunits in the rat spinal cord and in periaqueductal gray. J. Neurosci. 13:1993;5009-5028.
48. Tomiyama M., Rodriguez-Puertas R., Cortés R., Christnacher A., Sommer B., Pazos A., Palacios J.M., Mengod G. Differential regional distribution of AMPA receptor subunit messenger RNAs in the human spinal cord as visualized by in situ hybridization. Neuroscience. 75:1996;901-915.
49. Troy C.M., Brown K., Greene L.A., Shelanski M.L. Ontogeny of the neuronal intermediate filament protein, peripherin, in the mouse embryo. Neuroscience. 36:1990;217-237.
50. 2+ uptake are selectively vulnerable to AMPA/kainate receptor-mediated injury. Neurobiol. Dis. 1:1994;101-110.
51. Viana F., Van Den Bosch L., Missiaen L., Vandenberghe W., Droogmans G., Nilius B., Robberecht W. Mibefradil (Ro 40-5967) blocks multiple types of voltage-gated calcium channels in cultured rat spinal motoneurones. Cell Calcium. 22:1997;299-311.
52. Virgo L., Samarasinghe S., de Belleroche J. Analysis of AMPA receptor subunit mRNA expression in control and ALS spinal cord. NeuroReport. 7:1996;2507-2511.
53. Wenthold R.J., Yokotani N., Doi K., Wada K. Immunocytochemical characterization of the non-NMDA glutamate receptor using subunit-specific antibodies. J. Biol. Chem. 267:1992;501-507.
54. Westergaard N., Fosmark H., Schousboe A. Metabolism and release of glutamate in cerebellar granule cells cocultured with astrocytes from cerebellum or cerebral cortex. J. Neurochem. 56:1991;59-66.
55. Williams T.L., Day N.C., Ince P.G., Kamboj R.K., Shaw P.J. Calcium-permeable α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors: a molecular determinant of selective vulnerability in amyotrophic lateral sclerosis. Ann. Neurol. 42:1997;200-207.
56. Yin H., Park D.D., Lindsay A.D., Weiss J.H. Spinal cord neurons are vulnerable to rapidly triggered kainate neurotoxicity in vitro. Brain Res. 689:1995;265-270.